XML 37 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Changes in Equity
$ in Thousands
USD ($)
shares
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Share capital
USD ($)
shares
Share capital
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
shares
Contributed surplus
USD ($)
Contributed surplus
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Accumulated deficit
USD ($)
Accumulated deficit
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
Foreign currency reserve
USD ($)
Foreign currency reserve
Opening balance after adjustment, cumulative effect at date of initial application
USD ($)
DSUs
USD ($)
DSUs
Share capital
USD ($)
shares
DSUs
Contributed surplus
USD ($)
RSUs
USD ($)
shares
RSUs
Share capital
USD ($)
shares
RSUs
Contributed surplus
USD ($)
Beginning balance (in shares) at Dec. 31, 2022 | shares     298,394,203                          
Beginning balance at Dec. 31, 2022 $ 1,158,911   $ 2,420,396   $ 300,764   $ (1,560,759)   $ (1,490)              
Changes in Stock Holders Equity [Roll Forward]                                
Net loss (177,716)           (177,716)                  
Deferred share consideration related to acquisition (in shares) | shares     224,902                          
Deferred share consideration related to acquisition $ (15)   $ 3,053   (3,068)                      
Redeemed/exercised (in shares) | shares 152,120   152,120                 31,736   132,745 132,745  
Redeemed/exercised $ 335   $ 504   (169)           $ (171) $ 194 $ (365) $ (585) $ 1,494 $ (2,079)
Share-based compensation 10,959       10,959           171     $ 585    
Other comprehensive income (loss):                                
Defined benefit plan actuarial gain 970           970                  
Foreign currency translation for foreign operations $ (1,472)               (1,472)              
Ending balance (in shares) at Dec. 31, 2023 | shares 298,935,706     298,935,706                        
Ending balance at Dec. 31, 2023 $ 991,216 $ 991,216   $ 2,425,641   $ 306,042   $ (1,737,505)   $ (2,962)            
Changes in Stock Holders Equity [Roll Forward]                                
Net loss $ (324,245)           (324,245)                  
Redeemed/exercised (in shares) | shares 154,509   154,509                     347,901 347,901  
Redeemed/exercised $ 308   $ 472   (164)                 $ (855) $ 2,505 $ (3,360)
Share-based compensation 7,456       7,456           $ 0     $ 855    
Other comprehensive income (loss):                                
Defined benefit plan actuarial gain 913           913                  
Foreign currency translation for foreign operations $ (1,803)               (1,803)              
Ending balance (in shares) at Dec. 31, 2024 | shares 299,438,116   299,438,116                          
Ending balance at Dec. 31, 2024 $ 672,990   $ 2,428,618   $ 309,974   $ (2,060,837)   $ (4,765)